# Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.

> **NCT06601998** · — · RECRUITING · sponsor: **Hellenic Institute for the Study of Sepsis** · enrollment: 650 (estimated)

## Conditions studied

- Pneumonia, Community-Acquired
- COVID-19 Pneumonia
- Cardiovascular Diseases

## Interventions

- **OTHER:** Blood samples and Oropharyngeal swab
- **OTHER:** Six-minute walk test, Spirometry, ECG, Heart ultrasound and cardiopulmonary exercise stress testing, Completion of questionnaires of symptoms

## Key facts

- **NCT ID:** NCT06601998
- **Lead sponsor:** Hellenic Institute for the Study of Sepsis
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-08
- **Primary completion:** 2027-11-08
- **Final completion:** 2028-06-08
- **Target enrollment:** 650 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06601998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06601998, "Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06601998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
